United Arab Emirates (UAE) IVF (in-vitro fertilization) Market Overview, 2029

Over the last few decades, the United Arab Emirates (UAE) has seen significant developments in healthcare services and infrastructure, and the IVF industry is no exception. IVF has grown to be a major part of the nation's healthcare system, serving both locals and visitors who are looking for reproductive therapies. The UAE's IVF industry is distinguished by its cutting-edge facilities, skilled medical staff, and kind regulatory framework. A wide range of assisted reproductive technologies (ART), such as IVF, ICSI (Intracytoplasmic Sperm Injection), egg freezing, and pre-implantation genetic testing, are available in premier hospitals and fertility clinics throughout the United Arab Emirates. The UAE's IVF industry is growing due in large part to the government's dedication to funding medical advancements and infrastructure improvements. People from all over the world seeking fertility treatments find the country to be an appealing destination because to its strategic location, first-rate amenities, and lenient immigration restrictions. Due to the population's diversity in culture, the United Arab Emirates requires customised fertility treatment plans that take into account the needs of different racial and cultural backgrounds. In order to ensure inclusion and sensitivity in the provision of care, fertility clinics in the United Arab Emirates are skilled at attending to the particular requirements and preferences of patients from various ethnic and religious backgrounds. Within the UAE's IVF industry, research and innovation have received more attention in recent years. Collaborations between domestic organisations and foreign partners have made it easier for information and skills to be shared, which has improved the success rates of fertility treatments and advanced the field of reproductive medicine. The high expense of treatment, the lack of insurance coverage for infertility therapies, and the stigmas attached to fertility problems in society remain obstacles facing the IVF industry in the United Arab Emirates despite its progress. Initiatives to improve pricing, increase knowledge, and provide a friendly atmosphere for those receiving fertility therapy are being implemented in an attempt to solve these issues.

According to the research report " UAE Infertility Treatment Market Overview, 2029," published by Bonafide Research, the UAE Infertility Treatment market was valued at more than USD 87 Million in 2023. The in vitro fertilisation (IVF) industry is growing in the United Arab Emirates due to a few major factors. First and foremost, a major contributing factor is the growing knowledge and acceptance of assisted reproductive technologies among infertile couples. Second, people from all over the world seeking top-notch IVF treatments are drawn to prominent fertility clinics and hospitals due to their modern medical infrastructure and experience. The industry's growth is further supported by advantageous laws and policies, such as those that guarantee insurance coverage for reproductive procedures and encourage medical travel. Furthermore, the UAE is becoming a major centre for fertility treatments due to cultural trends away from early marriage and childbirth as well as socioeconomic reasons including increased disposable incomes and urbanisation that drive demand for IVF services.
The United Arab Emirates (UAE) offers a dynamic environment for assisted reproductive technology (ART), accommodating several kinds of in vitro fertilisation (IVF) cycles. Every kind of cycle has a certain meaning and serves a range of purposes and situations. Fresh Non-donor IVF rounds are a popular option for many couples seeking fertility therapy in the United Arab Emirates. By stimulating the ovaries to create numerous eggs, this approach entails harvesting the eggs and fertilising them with sperm in a lab setting. The goal of transferring the resultant embryos to the uterus is successful i mplantation. Fresh Non-donor IVF cycles provide families struggling with infertility in the United Arab Emirates with hopeful results thanks to advances in technology and medical knowledge. In the UAE's reproductive environment, the use of frozen non-donor IVF cycles is gradually gaining traction. By freezing and storing the embryos for later use, this method preserves embryos from a prior Fresh IVF session. Couples can undertake embryo transfer at a time that best suits their needs and preferences because to the flexibility this approach offers. Furthermore, the success rates of frozen non-donor IVF cycles are frequently equivalent to those of fresh cycles, which adds to their rising appeal in the United Arab Emirates. For individuals and couples seeking children in the United Arab Emirates, frozen donor IVF cycles have been a feasible alternative in recent times. In this procedure, donated eggs and/or sperm are used. These are fertilised, cultivated into embryos, and then stored for later use. Donor gametes open up new options and provide a different route to parenthood for people who are struggling with infertility. There has been a noticeable increase in demand for frozen donor IVF cycles in the United Arab Emirates due to rising knowledge and acceptance of donor-assisted reproductive treatments. Another option for individuals and couples starting their fertility journey in the United Arab Emirates is to use fresh donor IVF cycles. With this method, newly recovered donor eggs are fertilised with sperm to produce embryos that may be transferred. Because fresh donor IVF cycles have a high success rate, they are a desirable choice for those who want to increase their chances of getting pregnant. Fresh donor egg availability also makes customised treatment regimens based on each patient's needs possible, which adds to the UAE's rising inclination towards this cycle type. Within the constantly changing field of assisted reproduction, every type of IVF cycle has its own benefits and things to keep in mind. Although Frozen Non-donor IVF cycles are more convenient and have similar success rates, Fresh Non-donor IVF cycles have historically been more common in the UAE. Concurrently, the increasing recognition of donor-assisted reproductive therapies is changing the terrain, as both fresh and frozen donor IVF cycles are becoming more popular among people and couples hoping to become parents.

The growth trajectory of different end users in the healthcare industry is unique and promising in the dynamic landscape of the United Arab Emirates (UAE). Fertility clinics are unique in that they are driving a revolution in reproductive care throughout the United Arab Emirates. These clinics provide compassionate and effective care to address infertility difficulties, meeting the increasing demand for assisted reproductive procedures with state-of-the-art technologies and innovative therapies. Fertility clinics are essential in rewriting the story of parenting as the UAE adopts modern family dynamics and sees an increase in infertility cases. This has resulted in significant development and innovation in the healthcare sector. Hospitals and surgical centres exert their supremacy as essential foundations of the UAE's healthcare system in simultaneously. These centres, which are well-known for their top-notch infrastructure and extensive medical offerings, maintain the greatest standards of patient care and medical brilliance. Both locals and medical tourists look to them as rays of hope and healing for anything from simple surgery to intricate treatments. Hospitals and surgical centres are resolute in their commitment to raising healthcare standards and promoting a culture of wellness and accessibility as the UAE maintains its position as a top destination for healthcare. Cryobanks stand out in this healthcare environment as quiet but vital contributors to scientific and medical research in the United Arab Emirates. Cryobanks, which focus on storing biological material including sperm, eggs, and embryos, help advance the fields of regenerative medicine, genetics, and fertility preservation. Cryobanks are essential to preserving healthcare's future as the need for individualised treatment approaches rises and provide hope to those with infertility issues or hereditary disease predispositions. Research institutes in the United Arab Emirates (UAE) drive innovation and advancement in a range of medical fields, resulting in groundbreaking discoveries. These institutions, which have cutting-edge resources and multidisciplinary knowledge, act as incubators for novel research projects in fields like genomics and stem cell treatment. Research institutions in the United Arab Emirates (UAE) facilitate the conversion of scientific information into practical medical solutions by promoting collaboration among academics, industry, and healthcare practitioners. This approach positions the UAE as a global leader in medical innovation.
Regarding assisted reproductive technology, the United Arab Emirates (UAE) has a heterogeneous landscape of IVF clinics meeting a range of reproductive requirements. Conventional IVF, which is based on sperm fertilising eggs in a lab, is one of the basic techniques within this range. This method is still a mainstay at reproductive clinics in the United Arab Emirates, providing a complete answer for infertile couples. When it comes to treating certain male infertility problems, IVF with ICSI (Intracytoplasmic Sperm Injection) is a more prominent approach than traditional IVF. ICSI, which is very used in the United Arab Emirates, is the process of directly injecting one sperm into an egg to increase the likelihood of successful fertilisation. This exact technique has become well-known for working well in situations when there are insufficient sperm or insufficient sperm motility, which is why couples in the area seeking fertility treatments choose it. The reproductive scene in the United Arab Emirates has witnessed a notable surge in the use of donor egg IVF procedures. This method, which acknowledges the complexity of infertility, gives couples hope even in cases when the female partner may experience difficulties with egg quality or production. Couples may now look forward to motherhood with renewed hope thanks to the breakthroughs in reproductive medicine accessible in the United Arab Emirates when they use donor eggs. Also to these tried-and-true techniques, fertility clinics in the UAE welcome innovation and look into new ways to treat infertility. Whether via genetic screening, customised treatment plans, or sophisticated embryo selection methods, these cutting-edge methods highlight the UAE's healthcare sector's dedication to provide state-of-the-art solutions catered to individual requirements.


?

Considered in this report
• Historic year: 2018
• Base year: 2023
• Estimated year: 2024
• Forecast year: 2029



Aspects covered in this report
• IVF market Outlook with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By cycle
• Fresh Non-donor IVF Cycle
• Frozen Non-donor IVF Cycle
• Frozen donor IVF Cycle
• Fresh donor IVF Cycle

By Conventional IVF
• Conventional IVF
• IVF with ICSI (Instracytoplasmic Sperm Injection)
• IVF With Donor Eggs
• other

By End user
• Fertility Clinics
• Hospital & Surgical Centers
• Cryobanks
• Research institute

The approach of the report:
This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience
This report can be useful to industry consultants, manufacturers, suppliers, associations, and organizations related to the IVF industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.